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1. Introduction 
Serotonin has important central nervous ystem 
functions [1 ]. It has been implicated as an excitatory 
neurotransmitter and its altered levels contribute to 
psychopathic conditions like schizophrenia [2]. The 
high specificity of neurotransmitters suggests that 
their actions are mediated by specific binding to a 
receptor site on the synaptic plasma membrane. 
Marchbanks has shown that serotonin binds to nerve 
ending particles with three major binding affinities 
[3]. The high affinity binding site (Ka%106 M -1 ) is 
recovered in n-butanol extracts of brain. Binding is 
inhibited by d-LSD and destroyed on neuraminidase 
treatment. Gangliosides have been suggested as the 
serotonin binding component and consequently as the 
possible 'receptor' site. Gangliosides are generally 
located on the outer surface of nerve cells [4]. The 
ability of purified gangliosides to bind serotonin in 
aqueous olution has been demonstrated [5,6]. We 
describe in this communication the results of an 
1H n.m.r, study, of the interaction of serotonin with 
monkey brain gangliosides. 
2. Experimental procedures 
Mixed gangliosides were isolated from monkey 
brain, by the procedure described by Gammack [7]. 
Concentrated aqueous olutions of gangliosides were 
exhaustively dialysed against 0.1 M EDTA, glass 
distilled water and freeze dried, to yield a cream 
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coloured fluffy solid. Brain lipids were extracted by 
the method of Bligh and Dyer [8]. Dipalmitoyl 
lecithin and serotonin were obtained from Sigma 
Chemical Co. 
N.m.r. spectra were recorded at 60 MHz, on a 
Varian T-60 spectrometer at 35°C. Serotonin, as the 
oxalate or creatinine sulfate salt, was dissolved in 
D20 (30-50 mg/ml) and solutions containing 
weighed amounts of gangliosides and serotonin 
were added, to vary the glycolipid concentration. 
pH of n.m.r, samples were maintained at *4.0. 
Increasing the pH to 6.0 had no effect on the studies 
reported. Fluorescence spectra were recorded on a 
Perkin-Elmer MP203 spectrofluorimeter. 
3. Results and discussion 
The n.m.r, spectrum of the indole protons of 
serotonin (I) is shown in fig.la and the peak assign- 
ments are indicated. 
H7 ll) 
Fig.1 b -d ,  show the effects of increasing concentra- 
tions of brain gangliosides on the serotonin spectrum. 
There is a dramatic broadening of the aromatic 
resonances, without observable shifts at 60 MHz. 
North-Holland Publishing Company - Amsterdam 313 






7!5 (~ PPM 7!0 
Fig. 1. Aromatic proton resonances of serotonin as a function 
of ganglioside concentration. Serotonin concentration 
40 mg/ml. Ganglioside concentration (a) O, (b) 5.6 mg/ml, 
(c) 15.8 mg/ml, (d) 47.5 mg/ml and (e) serotonin (33 mg/ml) 
+ lecithin (36.5 mg/ml). 
This is clear evidence that exchange, of serotonin 
molecules between bound and free states, is fast on 
the n.m.r, timescale. Gangliosides form high mol.wt. 
micelles (200 000 to 450 000), in aqueous olution. 
The critical micelle concentration for brain ganglio- 
sides is 0.015%, with about 200 molecules per micelle 
[7]. The n.m.r, experiments reported here, were 
carried out at ganglioside concentrations varying from 
0.078% to 1.6%. The correlation time, for serotonin 
bound to micellar aggregates, i  likely to be large 
leading to line broadening. Fig.2 is a plot of the change 
in line width of the indole protons as a ftmction of 
ganglioside concentration. It is clearly seen that 
H2 and H7 are broadened to a greater extent han 
H4 and H6. The -CHz- -  protons of the sidechain 
also broaden. However the complex nature of the 
multiplet prevents measurement of individual line 
widths. The observation of differential line broadening 
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Fig.2. Plot of the line broadening (&,~vl) of tire aromatic 
resonances of serotonin as a function of/2ganglioside 
concentration. 
for protons, at adjacent positions on an aromatic ring 
is evidence for the contribution of intermolecular 
dipolar interactions in the bound state. In free sero- 
tonin, H 6 and H7 must relax by mutual dipole dipole 
effects due to their proximity. Differential broadening 
implies tile close approach of a proton on the gang- 
lioside to HT. Similarly for H2, hydrogen atoms on the 
glycolipid appear to contribute to nuclear elaxation, 
by their closeness in space. Intramolecular contribu- 
tions arising from the ethylamine sidechain cannot be 
ruled out, although geometric onstraints make this 
less likely. Differential changes in correlation times 
for the four nuclei are ruled out, as they are attached 
to the rigid framework of the indole system. Inter- 
molecular dipolar interactions have been shown to 
cause differential relaxation of aromatic protons, on 
sulfonamide inhibitors bound to carbonic anhydrase 
[9]. Nuclear Overhauser Effects have been used to 
conclusively establish the existence of intermolecular 
dipolar interactions, in the complex formed between 
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Fig.3. Uncorrected fluorescence spectrum of serotonin in 
the presence of gangliosides. Serotonin (10 ~g/ml) in 10 mM 
Tris-HC1 buffer, pH 7.4. Ganglioside concentration, (a) 0, (b) 
20/~g/ml and (c) 200 ug/ml. Excitation wavelength, 310 nm. 
to n.m.r, samples and by extensive dialysis of 
ganglioside solutions against 0.1 M EDTA, yielded 
reproducible line broadening data. Further CuCI: up- 
to a concentration of 0.35 mM did not affect the 
serotonin spectrum. These results uggest a specific and 
strong interaction of serotonin with gangliosides, that 
is not mimicked by other lipid dispersions. Fig.3 shows 
the quenching of serotonin fluorescence on addition 
of gangliosides. This is also suggestive of an inter- 
molecular interaction. Preliminary n.m.r, experiments 
indicate that the phenotbiazine drug chlorpromazine, 
which has antiserotonergic a tivity [12], also binds to 
brain gangliosides. In view of the postulated role for 
gangliosides as the 'serotonin receptor' and the 
importance of phenothiazine drugs in medical practice, 
further spectroscopic investigation of this binding 
process is in progress. 
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tripeptides and neurophysin-II [ 10]. These experiments 
allow elucidation of the nature of the amino acid 
residues at the protein binding site. In principle, the 
identity of the spatially proximate hydrogen atoms in 
the ganglioside-serotonin complex can be determined 
by this technique. 
Fig. le shows that addition of dipalmitoyl lecithin 
dispersions to serotonin solutions does not cause 
appreciable broadening of the resonances. Whole brain 
lipids were also without effect. Attempts to detect 
line broadening on addition of subcellular fractions 
enriched in plasma membranes, from brain tissue, 
were also unsuccessful. Gangliosides are known to 
bind divalent ions [11 ]. The presence of trace para- 
magnetic ions like Cu 2÷ may lead to line broadening. 
Control experiments, carried out by addition of EDTA 
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